During the past decade, Department Of Neurosciences, Addenbrookes Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department Of Neurosciences, Addenbrookes Hospital" #1 collaborator was "Bayer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Department Of Neurosciences, Addenbrookes Hospital" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials). Many other conditions were trialed in "Department Of Neurosciences, Addenbrookes Hospital" in a lesser frequency.

Most popular intervention types in "Department Of Neurosciences, Addenbrookes Hospital" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Interferon beta-1a" (2 trials), "Alemtuzumab" (1 trials), "Alemtuzumab 12 mg" (1 trials) and "Alemtuzumab 24 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department Of Neurosciences, Addenbrookes Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department Of Neurosciences, Addenbrookes Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department Of Neurosciences, Addenbrookes Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department Of Neurosciences, Addenbrookes Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".